Drug combo provides 10 percent weight loss for obese in a one-year clinical trial
An investigational combination of drugs already approved to treat obesity, migraine and epilepsy produced up to a 10 percent weight loss in obese individuals participating in a one-year clinical trial, according to researchers at Duke University Medical Center Appearing online in The Lancet, the study found that treatment with the controlled-release combination therapy consisting of …